• Molecular NameViomycin
  • SynonymNA
  • Weight685.7
  • Drugbank_IDN/A
  • ACS_NO32988-50-4
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)-9.41
  • pkaN/A
  • LogD (pH=7, predicted)-15.14
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)0.16
  • LogSw (predicted, AB/LogsW2.0)1809260.0
  • Sw (mg/ml) (predicted, ACD/Labs)1000.0
  • No.of HBond Donors19
  • No.of HBond Acceptors23
  • No.of Rotatable Bonds10
  • TPSA390.36
  • StatusN/A
  • AdministrationIntramuscular injection
  • PharmacologyViomycin is a member of the tuberactinomycin family, a group of nonribosomal peptide antibiotics exhibiting anti-tuberculosis properties.
  • Absorption_value85.0
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A